Cabergoline Therapy Against Hyperadrenocorticism in a Dog

A 9-year-old male Labrador with chronic skin infection, alopecia, skin thinning, calcinosis cutis, and a pendulous abdomen was diagnosed with hyperadrenocorticism based on clinical and ultrasonographic findings, including increased ALP, hyperglycemia, hepatomegaly, and bilateral adrenal gland hyperplasia. The dog was treated with Cabergoline at 0.07 mg/kg orally every 3 days for 3 months, resulting in the gradual subsidence of clinical signs and uneventful recovery. The study suggests that Cabergoline is an effective alternative treatment for managing hyperadrenocorticism in dogs.